Tempus AI, Inc. (NASDAQ:TEM) is one of the 8 Best Genomics Stocks to Buy According to Analysts. On June 3, Tempus AI, Inc.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry ...

Mayo Clinic's Center for Individualized Medicine and genomic sequencing specialist Tempus announced a collaboration to provide personalized treatment for cancer patients based on analytics and machine ...

AI-powered data company Tempus AI announced it will acquire Paige, an AI-enabled diagnostic platform for oncologists and pathologists, for $81.25 million. Tempus said the acquisition will help the ...

The opportunity for Tempus AI lies within its data. The company is well connected to many healthcare companies and institutions all over the world, and it can use its vast data set to train advanced ...

On Nov. 4, Tempus AI reported revenue of $334.21 million, topping analyst estimates of $328.73 million and marking an 84.7% increase from a year earlier. The loss estimate of 17 cents was surpassed by ...

View Tempus AI, Inc. Class A TEM stock quote prices, financial information, real-time forecasts, and company news from CNN.